Archiwum hase³
visual acuity {VA} | autosomal dominant optic atrophy {ADOA} | central corneal thickness {CCT} | cerebral visual impairment {CVI} | Leber ’s hereditary optic neuropathy {LHON} | Partial optic disc atrophy | bilateral centrocecal scotoma | temporal pallor of the optic disc | Anion gap {AG} {An- Gap} | foveal threshold | Pattern electroretinogram {PERG} | optic nerve dysfunction | Graves’ orbitopathy | Persistent generalised lymphadenopathy {PGL} | Iimmune trombocytopenic purpura {ITP} | Heparin induced thrombocytopenia {HIT} | idiopathic thrombocytopenic purpura {ITP} | Optical coherence tomography {OCT} | large unstained cells {LUC} | Non-small cell lung carcinoma {NSCLC} | inhibitors of microtubule polymerization | Antimicrotubulin agents | Second-line treatment | progression-free survival {PFS} | non-resectable pancreatic cancer | locally advanced pancreatic cancer {LAPC} | Non-receptor tyrosine kinases {nRTKN} | isovolumic relaxation {IRV} | Anti-synthetase syndrome | restrictive lung disease | Forced vital capacity {FVC} | rectus femoris muscle | Glenohumeral internal rotation deficit {GIRD} | Shoulder impingement syndrome {SIS} | Golgi Tendon Organ {GTO} | Vestibulo-spinal reflex {VSR} | Complex Regional Pain Syndrome {CRPS} | Fibrodysplasia ossificans progressiva {FOP} | brain-gut axis | G protein coupled receptors {GPCR} | pulmonary embolism | squamous cell carcinoma {SCC} | umbilical cord blood {UCB} | reduced intensity conditioning {RIC} | nerve growth factor {NGF} | brain-derived neurothrophic factor {BDNF} | detrusor muscle hyperfunction | nucleic acid amplification techniques {NAT} | hepatocellular carcinoma {HCC} | major hydrophilic region | occult hepatitis B infection | reinduction protocol | neurotrophin receptor | amyloid precursor protein | cerebral granule neurons | cysteine rich domain | extracellular domain p75NTR | intracellular domain 75NTR | c-Jun N-terminal kinase | mitogen- activated protein kinase | protein kinase B {PKB} | nuclear factor kB | neurotrophin receptor interacting factor | neurotrophin 3 | phosphatidylinositol 3-kinase | small protein G from familly Rho | small protein G from Ras family | receptor-interacting protein {RIP} | tumor necrosis factor | TNF receptor associated factor | tyrosine kinase receptor {TKR} | Thrombin Activable Fibrinolysis Inhibitor {TAFI} | nerve growth factor {NGF} | Heamatopoietic Stem Cell Transplantation | IgA deficiency | Severe Combined Immunodeficiency {SCI} | Common Variable ImmunoDeficiency { CVID } | X-Linked Agammaglobulinemia | Transient Hypogammaglobulinemia of Infancy | antigen presenting cells | B cells receptor | cytotoxic T cell antigen 4 | chronic granulomatous disease {CGD} | Antibody-drug conjugate {ADC} | antisense bFGF gene transfer | ntibody dependent cellular phagocytosis {ADCP} | Pathogen-associated molecular patterns {PAMP} | secreted alkaline phosphatase {SEAP} | lipofection | waist–hip ratio {WHR} | familiar adenomatous polyposis {FAP} | primitive neuroectodermal tumour {PNET} | kynurenine pathwa | diffuse parenchymal lung disease {DPLD} | pulmonary alveolar proteinosis {PAP} | Focal segmental glomerulosclerosis {FSGS} | cryptogenic fibrosing alveolitis | gastrointestinal stromal tumor {GIST} | bronchoalveolar lavage fluid {BALF} | Continuous erythropoietin receptor activator {CERA} | bronchoalveolar lavage fluid {BALF} | metronomic therapy | Highly superior autobiographical memory {HSAM} | cytosol | prevertebral plexus | Abortive polio | accessory meningeal artery | Middle meningeal artery | acellular pertussis vaccine | acetabular floor | Abdominal actinomycosis | abdominal tenderness | achlorhydria | severe psychomotor impairment {SPMI} | bedridden child | proximal interphalangeal joints {PIP} | metacarpophalangeal joints {MCP} | bacterial peptidoglycan {PGN} | Peptidoglycan recognition protein 1 {PGLYRP1} | implantable cardioverter defibrillator {ICD} | adeno-associated virus {AAV} | Multiplicity of infection {MOI} | Fasting induced adipose factor {FIAF} | smouldering multiple myeloma {SMM} | non-obese diabetic {NOD} mouse | antineutrophil cytoplasmic antibodies (ANCA) | Microscopic polyangitis (MPA) | Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) | Antineutrophil cytoplasmic antibodies {ANCA}-associated vasculitis {AAV} | fibrosing cholestatic hepatitis {FCH} | Experimental autoimmune encephalomyelitis (EAE) | tumor associated macrophage {TAM} | Variable frag - ments of heavy chain antibodies {VHH} | domain antibodies {dAbs} | Complement dependent cytotoxity {CDC} | Single-chain variable fragment {scFV} | Chilblain lupus erythematosus {CHLE} | Lichen sclerosus et atrophicus {LSA} | glymphatic system | Blood–Cerebrospinal Fluid Barrier {BCSFB} | Immune checkpoints | Response evaluation criteria in solid tumors {RECIST} | Tumor-infiltrating lymphocytes {TILs} | Neonatal Fc receptor {FcRn} | Castration-resistant prostate cancer {CRPC)} | Negative Pressure Wound Therapy {NPWT} | Raf murine sarcoma viral oncogene homolog B1 {BRAF} | Cytotoxic T-lymphocyte-associated antigen-4 {CTLA-4} | Herpesvirus entry mediator {HVEM} | Metastatic castration resistant prostate cancer {mCRPC} | Response Evaluation Criteria in Solid Tumors {RECIST} | T cell immunoglobulin and mucin domain 3 {TIM-3} | Overactive bladder {OAB} | Detrusor wall thickness {DWT} | Cerebral granule neurons {CGNs} | Small protein G from Ras family {Ras} | Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome {IPEX} | Iron deficiency anemia {IDA} | choroid plexus papilloma {CPP} | Symptomatic intracerebralhaemorrhage {SICH} | intracerebroventricular {i.c.v} | hypoxia-inducible factor 1 {HIF-1} | mitogen activated protein kinase kinase kinase {MKKK} | Tropomyosin-related kinase, tyrosine kinase receptor {Trk A} | Autoimmune diseases | constrictive pericarditis | Recurrent pericarditis | relapsing pericarditis | pericardial effusion | Open reading frame {ORF} | Basal core promotor {BCP} | Major hydrophilic region {MHR} | Occult hepatitis B infection {OBI} | Heamatopoietic Stem Cell Transplantation {HSCT} | ST-segment elevation myocardial infarction {STEMI} | Chemokine receptor CXCR4 | Hematological recovery | antiangiogenic therapy | Pseudomembranous colitis | restrictive cardiomyopathy | Antibiotic Antimycotic Solution {AAS} | Adipose Derived Stem Cells {ADSC} | Alpha-Smooth Muscle Actin {αSMA} | Adipose-tissue-derived Mesenchymal Stem Cells {AT-MSC} | Bone Marrow Mesenchymal Stem Cells {BM-MSC} | cAMP Response Element-binding Protein {CREB } | Glial Cell line-Derived Neurotrophic Factor {GDNF} | Glia Fibrillary Acidic Protein {GFAP} | Hypoxia Inducible Factor {HIF} | Microtubule Associated Protein {MAP} | Mononuclear Cell {MNC} | Neural Crest-derived Stem Cells {NCSC} | Per-AHR-ARNT-Sim {PAS} | Population Doubling Time {PDT} | Wharton Jelly {WJ} | Wharton Jelly Mesenchymal Stem Cells {WJ-MSC} | Mesenchymal Stromal Cells {MSC} | Mohs Micrographic Surgery | Frozen sections technique | histological tissue processing |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
